Reagents and consumables for ventana medical systems (VMS) benchmark ultra immunostainers

Ended Awarded

Contract number
75N91019F00134
Awardee
Awarding agency
Obligated
$51,944

Award facts

Opportunity
Contract value 100% obligated
$51,944.03 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
San Diego, CA 92122, USA

Award details come from SAM.gov/FPDS.

Quick answers

Who was awarded contract 75N91019F00134?

75N91019F00134 was awarded to Roche Diagnostics Corporation by National Cancer Institute (National Institutes of Health) on February 21, 2019.

How much is contract 75N91019F00134 worth?

The government has obligated $51,944 on 75N91019F00134.

Is contract 75N91019F00134 an order under another contract?

Yes. 75N91019F00134 is a delivery order under HHSN261201700010I, an indefinite delivery contract.

Was contract 75N91019F00134 competed?

The extent of competition for 75N91019F00134 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award